Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Bando

Showing results (1-10 of 126) with videos related to

Pageof 13
Sort By:
Breast Cancer (Tokyo, Japan)|May 9, 2007
Vascular endothelial growth factor and bevacitumab in breast cancerHiroko Bando
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 11, 2012
[Breast cancer-local treatment-]Hiroko Bando
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 15, 2007
[The treatment of primary breast cancer, surgical approach]Hiroko Bando
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Adjuvant endocrine therapy in premenopausal breast cancer]Hiroko Bando
Breast Cancer (Tokyo, Japan)|June 12, 2013
Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in JapanHiroko Bando
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[VEGF (vascular endothelial growth factor)]Hiroko Bando, Masakazu Toi
The New England Journal of Medicine|October 6, 2021
Adjuvant Olaparib in BRCA-Mutated Breast CancerAoi Hoshi, Hiroko Bando, Ikuo Sekine
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 23, 2003
Decision tree and paradigms of primary breast cancer: changes elicited by preoperative therapyMasakazu Toi, Hiroko Bando, Shigehira Saji
Journal of Multidisciplinary Healthcare|April 10, 2025
Clinical Utility of Integrated Multidisciplinary Patient-Centered Information in Breast Cancer Care: A Mixed Methods StudyAtsuko Sugiyama, Kazuki Utsunomiya, Katsuhiko Fujimoto, et al.
Nihon Geka Gakkai Zasshi|December 14, 2002
[Current indications for mastectomy in patients with breast cancer]Chikashi Nakanishi, Masakazu Toi, Shigehira Saji, et al.
Pageof 13

Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Breast Cancer (Tokyo, Japan)|May 9, 2007
Vascular endothelial growth factor and bevacitumab in breast cancerHiroko Bando
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 11, 2012
[Breast cancer-local treatment-]Hiroko Bando
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 15, 2007
[The treatment of primary breast cancer, surgical approach]Hiroko Bando
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Adjuvant endocrine therapy in premenopausal breast cancer]Hiroko Bando
Breast Cancer (Tokyo, Japan)|June 12, 2013
Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in JapanHiroko Bando
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 10, 2005
[VEGF (vascular endothelial growth factor)]Hiroko Bando, Masakazu Toi
The New England Journal of Medicine|October 6, 2021
Adjuvant Olaparib in BRCA-Mutated Breast CancerAoi Hoshi, Hiroko Bando, Ikuo Sekine
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|May 23, 2003
Decision tree and paradigms of primary breast cancer: changes elicited by preoperative therapyMasakazu Toi, Hiroko Bando, Shigehira Saji
Journal of Multidisciplinary Healthcare|April 10, 2025
Clinical Utility of Integrated Multidisciplinary Patient-Centered Information in Breast Cancer Care: A Mixed Methods StudyAtsuko Sugiyama, Kazuki Utsunomiya, Katsuhiko Fujimoto, et al.
Nihon Geka Gakkai Zasshi|December 14, 2002
[Current indications for mastectomy in patients with breast cancer]Chikashi Nakanishi, Masakazu Toi, Shigehira Saji, et al.
Pageof 13